Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Short Article, Jldt Vol: 10 Issue: 4
Epidemiological Profile of Acute Viral Hepatitis in world
Janifer Steinbeck*
Department of hepatology, Laboratory of Liver, Pancreas and Motility, University Hospital, Favaloro Foundation, Argentina
*Corresponding Author: Janifer Steinbeck,Department of hepatology,
Laboratory of Liver, Pancreas and Motility, University Hospital, Favaloro Foundation, Argentina; E-mail: JSteinbeck@yahoo.com
Received: July 09, 2021 Accepted: July 23, 2021 Published: August 09, 2021
Citation: Steinbeck J (2021) Epidemiological Profile of Acute Viral Hepatitis in world. J Liver Diseases 2021, 10:4
Abstract
Viral liver disease is one of the major public health concerns around the world but until not very long ago it has drawn little attention or money from worldwide health policymakers. Every year people die from viral liver disease-related liver disease and liver cancer. However, most of the infected population are unaware of their condition. This population have significant blocking or stopping things to overcome such as lack of knowing about something, weakness that could be used to hurt someone or something, increased moving from one place to another, disease mark of shame, unfair treatment based on skin color, age, etc., as well as poor health useful things/valuable supplies, conflict in policy development and program putting into use. Even though there is the existence of putting into use infection control measures over the last twenty years destruction/permanent removal or significant disease reduction remains hard to see/hard to catch. This study aims to present the current worldwide number status and examines possible elimination success plans/ways of reaching goals. The information for this research were gotten through a well-thoughtout review, published scientific literatures, the official websites of different government organisations, international public health organisations and in other countries recognised legal/law-based bodies over a period of time.
Keywords: Viral Liver disease,HBV
Introduction
Viral liver disease results from swelling of the liver, caused by a viral infection. Although “widespread disease blood disease” has existed since very old civilisation, it is only in the last twenty years that viral disease causes of liver disease have been identied. Almost all such infections are caused by five viruses, namely liver disease A virus (HAV), liver disease B virus (HBV), liver disease C virus (HCV), liver disease D virus (HDV), and liver disease E virus (HEV). Viral liver disease is a major public health concern, infecting millions of people every year; some infections after that lead to hepatocellular cancer (HCC), liver liver disease and deaths among signicant proportion of patients. Prevention and control success plans/ways of reaching goals for viral liver disease such as raising knowing about something through public education, vaccination, blood transfusion safety success plans/ways of reaching goals, early identification of a disease or problem, or its cause and effective medical support can be put into use, and novel actions that help bad situations are available.
In this review, worldwide the study of what causes disease of viral liver disease and effective control methods are summarised. Data from key recent related to watching or recording something studies, scientific fact-finding experiments, case reports or case series were identified and their data creation/combination to summarise the disease heavy load, related to where mountains, rivers, cities, etc., are located distribution and effective control measures of viral liver disease. Prevention and control success plans/ways of reaching goals for viral liver disease such as raising knowing about something through public education, vaccination, blood transfusion safety success plans/ways of reaching goals, early identification of a disease or problem, or its cause and effective medical support can be put into use, and novel actions that help bad situations are available. In this review, worldwide the study of what causes disease of viral liver disease and effective control methods are summarised. Data from key recent related to watching or recording something studies, scientific fact-finding experiments, case reports or case series were identified and their data creation/combination to summarise the disease heavy load, related to where mountains, rivers, cities, etc., are located distribution and effective control measures of viral liver disease. American Association for the study of Liver Disease, the Asian Pacific Association for the Study of Liver and Gastroenterology community of people/all good people in the world of Australia. Computer files full of information including Science Citation Index were expanded by using computer file full of information-specific controlled vocabulary where available and general free text terms. Other clearly connected or related websites were also explored, including those of the Worldwide Health Library, Centres for Disease Control and Prevention, WHO, United States Food and Drug Administration related to Europe Medicines service business/government unit/power/functioning, and Australian Government Department of Health. In addition other search engines such as Google Educated person, Research Gate and Science Direct were explored using the key search terms. The current status of viral liver disease, action plans and options for controlling sudden beginnings of bad things like disease have been discussed.
References
- World Health Organization(WHO). Prevention and Control of Viral Hepatitis Infection: Frame Work for Global Action. 2012.
- Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol 2013; 10: 553-562
- Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012; 30: 2212-2219.
- Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, et al. Hepatitis E. Lancet 2012; 379: 2477-2488.
